Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Surgery Today|July 29, 2026
Is stent graft placement superior to transarterial embolization in the treatment of patients with extraluminal post-pancreatectomy hemorrhage?Yuki Hisano, Hirohisa Okabe, Hiromitsu Hayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 22, 2016
Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinomaTakayoshi Kaida, Hidetoshi Nitta, Yuki Kitano, et al.
Anticancer Research|March 2, 2018
A Case of 15-Year Recurrence-free Survival After Microwave Coagulation Therapy for Liver Metastasis from Gastric CancerKoichi Kinoshita, Toru Beppu, Tatsunori Miyata, et al.
Cancer Science|November 15, 2018
PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosisMasayo Tsukamoto, Katsunori Imai, Takatsugu Ishimoto, et al.
Surgery Today|August 30, 2019
Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomyHirohisa Okabe, Yo-Ichi Yamashita, Risa Inoue, et al.
Anticancer Research|December 27, 2017
Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic DisseminationKunitaka Kuramoto, Toru Beppu, Hidetoshi Nitta, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2018
Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinomaShigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, et al.
Surgery Today|August 22, 2018
Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumorsTakashi Matsumoto, Hirohisa Okabe, Yo-Ichi Yamashita, et al.
Oncotarget|May 15, 2018
Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinomaTatsunori Miyata, Yo-Ichi Yamashita, Yoshifumi Baba, et al.
Surgery Today|November 25, 2019
Clinical role of serum programmed death ligand 1 in patients with hepatocellular carcinoma: Where does it come from?Hatem A Elmezayen, Hirohisa Okabe, Yoshifumi Baba, et al.
Pageof 10